Could Fibroblast Activation Protein (FAP)-Specific Radioligands Be Considered as Pan-Tumor Agents?
Chiara Da Pieve, Marta Costa Braga, David R Turton, Frank A Valla, […]
Chiara Da Pieve, Marta Costa Braga, David R Turton, Frank A Valla, […]
Chiara Da Pieve, Marta Costa Braga, David R Turton, Frank A Valla, […]
Liang Zhao, Jianhao Chen, Yizhen Pang, Kaili Fu, Qihang Shang, Hua Wu, […]
Dulles, VA – November 10, 2021 – SOFIE Biosciences (SOFIE), an established US manufacturer and developer […]
Katharina Dendl 1,2 Stefan A. Koerber 3,4,5 Clemens Kratochwil 1 Jens […]
Dulles, VA – October 12, 2021 – SOFIE Biosciences (SOFIE), an established US manufacturer and […]
Surachet Imlimthan, Euy Sung Moon, Hendrik Rathke, Ali Afshar-Oromieh, Frank Rösch, Axel […]
SOFIE, an established Radiopharmaceutical Contract Manufacturing Organization and GMP radiopharmacy network, has promoted the company’s […]
The Society for Brain Mapping and Therapeutics (SBMT), the leading multi-specialty association for Brain Mapping, is […]
SOFIE, an established Radiopharmaceutical Contract Manufacturing Organization and GMP radiopharmacy network, will be commercially […]